← Back to Search

Screening for Psychosis

N/A
Waitlist Available
Led By Annette Crisanti, PhD
Research Sponsored by University of New Mexico
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
15-30 year-old college students who present to the University of New Mexico (UNM) Early Program or the UNM CONNECT program for an intake
agree to participate in the study.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at 1 day ( one time point only, which is upon admission to coordinated specialty care (csc) and is operationalized as the onset of symptoms and admission to csc for first episode psychosis.)
Awards & highlights

Study Summary

This study is evaluating whether a program which identifies students at risk for psychosis can help improve their outcomes.

Eligible Conditions
  • Psychosis
  • First Episode Psychosis
  • High Risk for Psychosis

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at 1 day (one time point only, which is upon admission to coordinated specialty care (csc) and is operationalized as the number of steps between the onset of symptoms and admission to csc for first episode psychosis or clinic high risk.)
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at 1 day (one time point only, which is upon admission to coordinated specialty care (csc) and is operationalized as the number of steps between the onset of symptoms and admission to csc for first episode psychosis or clinic high risk.) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Duration of Untreated Psychosis (DUP)
Secondary outcome measures
Number of steps to coordinated specialty care
Perceived barriers to seeking psychological help

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Screening Plus Warm Hand-OffExperimental Treatment2 Interventions
Addition of a warm hand-off to coordinated specialty care (CSC) for those determined eligible on the screening tool.
Group II: ScreeningExperimental Treatment1 Intervention
Implementation of the Prodromal Questionnaire - Brief, which is a screening tool to detect risk of psychosis.
Group III: Treatment as UsualActive Control1 Intervention
Treatment as usual enhanced with a brief psychosis literacy training (45-60 minutes) for the counselors at the university's student health and counseling center

Find a Location

Who is running the clinical trial?

University of New MexicoLead Sponsor
371 Previous Clinical Trials
3,529,016 Total Patients Enrolled
1 Trials studying Psychosis
35 Patients Enrolled for Psychosis
National Institute of Mental Health (NIMH)NIH
2,774 Previous Clinical Trials
2,674,278 Total Patients Enrolled
46 Trials studying Psychosis
10,694 Patients Enrolled for Psychosis
Annette Crisanti, PhDPrincipal InvestigatorUniversity of New Mexico

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Mar 2025